Search

Issue
Title
Authors
Topical issues concerning modern lipid-lowering therapy
Susekov A.V.
Achieving target lipid levels with statin and ezetimibe combination therapy
Shaposhnik I.I., Genkel V.V.
WHICH ASPECTS ARE THE MOST SIGNIFICANT IN RUSSIAN AND EUROPEAN GUIDELINES? INTERVIEW
Role of rosuvastatin in the primary and secondary prevention of cardiovascular disease
Yalymov A.A., Shekhyan G.G., Shchikota A.M., Zadionchenko V.S.
Taktika vedeniya pozhilykh bol'nykh s ishemicheskoy bolezn'yu serdtsa. Aktsent na tsitoprotektsiyu
Komissarenko I.A., Mikheeva O.M.
Profilaktika ateroskleroza: tseli gipolipidemicheskoy terapiii real'nye vozmozhnosti rozuvastatina
Bubnova M.G.
Gipolipidemicheskaya terapiya i reoferez pri dislipoproteidemiyakh
Konovalov G.A., Zvezdkin P.V., Khayutina T.L., Filonenko I.V., Akopyan V.S., Karneeva O.V., Doroshchenko A.D., Kurganskaya T.S.
Possibilities of combination lipid-lowering therapy in a patient with very high cardiovascular risk (dinical case)
Sedykh D.Y., Fedorova N.V., Kashtalap V.V.
Statins pharmacogenetics: metabolizing enzymes and transporters polymorphisms role
Leonova M.V., Gaysenok O.V., Leonov A.S.
Statin therapy and the risk of developing diabetes: the debate continues
Karpov R.S., Koshelskaya O.A.
Statiny i sakharnyy diabet: problema, mif ili real'nost'?
Gilyarevskiy S.R., Golshmid M.V.
Antiaritmicheskiy effekt statinov pri zheludochkovykh narusheniyakh ritma vysokoy gradatsii i mertsatel'noy aritmii
Aronov D.M.
Simvastatin: vnov' trebuetsya peresmotr standartov lecheniya bol'nykh s vysokim riskom oslozhneniy ateroskleroza
Zateyshchikov D.A.
Statins in certain patient populations: scientific evidence and algorithms for practicing physicians
Susekov A.V.
Statins and diabetes mellitus: cardiologist’s point of view
Ostroumova O.D.
Iatrogenic risk factors and correction of dyslipidemia after liver transplantation
Kosmacheva E.D., Babich A.E.
Pervichnaya i vtorichnaya profilaktika‌‌ateroskleroza: kak vybrat' statin?
Vaulin N.A.
Atorvastatin v lechenii bol'nykh sakharnym diabetom 2-go tipa (k 30-letiyu otkrytiya statinov)
Galyavich A.S.
Goals and possibilities of combined hypolipidemic therapy of cerebrovascular diseases associated with dyslipidemia
Sabirov I.S., Murkamilov I.T., Fomin V.V., Yusupov F.A.
Dyslipidemia and atherosclerosis in type 2 diabetes mellitus patients. Statin therapy characteristics and comparative analysis: endocrinologist’s point of view
Demidova T.Y., Susareva O.V.
Dinamika izmeneniya sosudodvigatel'noy funktsii endoteliya i pokazateley remodelirovaniya serdtsa u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu na fone lecheniya rozuvastatinom
Bochenina Y.A., Kuznetsov G.E., Tenchurina L.R.
15 let Ursosan v Rossii Metabolicheskiy sindrom, nealkogol'naya zhirovaya bolezn' pecheni i statiny: komu, kogda i kak?
Drapkina O.M., Kostyukevich M.V.
Atorvastatin: rezul'taty ispytaniy pri nevysokom iskhodnom kholesterine lipoproteidov nizkoy plotnosti
Gratsianskiy N.A.
Hypolipidemic therapy: evidence-based effectiveness and new perspectives
Kudina E.V., Samkova I.A., Larina V.N.
Statins and the liver: a point of view from the gastroenterologist
Kazyulin A.N.
Algorithm of management of patients with suspected statininduced myopathy (clinical case of severe congenital myopathy developed along with of long-term statin therapy)
Deeva T.A., Drapkina O.M.
Atorvastatin vs simvastatin: sravnitel'nyy analiz s pozitsii dokazatel'noy meditsiny
Zadionchenko V.S., Shekhyan G.G., Snetkova A.A., Yalymov A.A.
Ingibitory GMG-KoA-reduktazy pri vtorichnoy profilaktike ateroskleroza: 30 let spustya
Susekov A.V.
STATINS AND COGNITIVE FUNCTIONS: ARE THERE ASSOCIATED DISORDERS OR PROTECTION FROM DEMENTIA?
Leonova M.V.
Statins and the liver: a point of view from the cardiologist
Ostroumova O.D.
Mnogofaktornyy podkhod k snizheniyu serdechno-sosudistogo riska: vozmozhnosti kombinirovannoy terapii amlodipinom i atorvastatinom
Protasov K.V.
Statiny – vizitnaya kartochka kardiologa
Mesto statinov v terapii bol'nykh sakharnym diabetom tipa 2
Galyavich A.S.
SECONDARY PREVENTION IN STABLE ANGINA
Kirichenko A.A.
Clinical studies of rosuvastatin from the GALAXY project in the context of the new EAS/ESC-2016 recommendations on dyslipidemia Part 1
Susekov A.V.
Lechenie kardiologicheskogo patsienta: kupirovanie simptomov ili snizhenie serdechno-sosudistogo riska
Rudenko A.V., Rudenko B.A.
Vremya razbrasyvat' kamni: rasshirenie pokazaniy k primeneniyu statinov
Gilyarevskiy S.R., Orlov V.A., Golshmid M.V., Kuz'mina I.M.
Statiny pri lechenii sakharnogo diabeta tipa 2
Susekov A.V.
CEREBROVASCULAR DISEASE AND STENOTIC LESION OF THE BRACHIOCEPHALIC ARTERIES: EPIDEMIOLOGY, CLINICAL MANIFESTATIONS, TREATMENT
Lemenev V.L., Luk'ianchikov V.A., Beliaev A.A.
Optimal drug therapy for patients with stenocardia and its impact on mortality
Mazur N.A.
Issledovanie effektivnosti primeneniya genericheskogo rozuvastatinapri tserebrovaskulyarnykh zabolevaniyakh
Sapari L., Fekher G.
Dislipidemiya kak faktor riska razvitiyaserdechno-sosudistykh zabolevaniy i oslozhneniy
Evdokimova A.G.
Gipolipidemicheskaya terapiya metabolicheskogo sindroma
Chazova I.E., Mychka V.B.
1 - 43 of 43 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies